Patent · US Active

Compositions and methods for antibodies targeting complement protein C5

US8241628B2 · kind B2 · utility

54Cited by

6References

20Claims

0Family size

Assignee

Novartis AG · CH

Inventors

Beate Diefenbach-Streiber · Windach, DE
Adina Eberth · Munich, DE
Braydon Charles Guild · Concord, US
Yong-In Kim · Westborough, US
Michael Roguska · Cambridge, US
Igor Splawski · Winchester, US

Key dates

Filing date	Aug 4, 2009
Grant date	Aug 14, 2012
Priority date	—
Expiry date	Feb 16, 2030

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/92
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

The present invention relates to antibodies targeting complement protein C5 and compositions and methods of use thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.